Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4130313

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CCC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1ccco1)C(C)C)C(C)C

Basic Information

ChEMBL ID CHEMBL4130313
Phase Preclinical
Structure Type MOL
InChI Key BHGBAICQFGWZLG-SIOAWTSHSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

645.8
MW (Da)
2.23
ALogP
8
HBA
5
HBD
184.9
PSA (Ų)
0.12
QED
1
Ro5 Violations
18
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C33H51N5O8
MW 645.80
Aromatic Rings 1
Heavy Atoms 46
NP-Likeness 0.11

Activity Summary

Ki 1 meas. best 5.17

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
Ki 5.17 5.17 6700.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked Ki = 6700.0 nM 5.17 Inhibition of SARS coronavirus Mpro using MCA-AVLQSGFR-Lys(Dnp)-Lys-NH as substr... 28624700

Literature References

PubMed DOI Target Context # Activities
28624700 10.1016/j.ejmech.2017.05.045 Unchecked 1

Data from ChEMBL 36 via Core Engine